Short Communication: Characterization of phenotypic and genotypic antibiotic resistance patterns in Escherichia coli isolates from bloodstream infections
Main Article Content
Abstract
Abstract. Tjampakasari CR, Stevina L, Paramita RI. 2026. Short Communication: Characterization of phenotypic and genotypic antibiotic resistance patterns in Escherichia coli isolates from bloodstream infections. Biodiversitas 27 (3): d270320. https://doi.org/10.13057/biodiv/d270320. Extraintestinal pathogenic Escherichia coli (ExPEC) is a leading cause of bloodstream infections (BSIs) worldwide and contributes substantially to the burden of antimicrobial resistance. The aim of this study was to evaluate the concordance between phenotypic antimicrobial susceptibility testing (AST) and genotypic resistance determinants identified by whole-genome sequencing (WGS) in E. coli BSI isolates. During the study period, 194 blood culture samples from patients with suspected BSIs were processed, of which 92 yielded positive results; 13 non-duplicate E. coli isolates (14.13% of positive cultures) were included in this single-center, exploratory study. Phenotypic resistance profiles were determined using the VITEK®2 Compact system, while WGS was performed to identify antimicrobial resistance genes, sequence types (STs), and resistance-associated mutations. Phenotypic resistance showed that resistance to ampicillin (7/13, 53.8%), ciprofloxacin (6/13, 46.2%), and ceftriaxone (5/13, 38.5%). Genomic analysis revealed β-lactam resistance genes predominantly associated with blaTEM-1B and its variants (blaTEM-116, blaTEM-141, and blaTEM-206), along with blaCTX-M-55; blaTEM-1B was the most frequently detected gene (4/13), followed by blaCTX-M-55 (2/13). Fluoroquinolone resistance was mainly linked to mutations within quinolone resistance-determining regions of gyrA and parC, as well as alterations affecting the AcrAB-TolC efflux system. Multilocus sequence typing using the Achtman scheme demonstrated high genetic diversity, with 12 distinct STs identified among 13 isolates, including ST73, ST117, ST410, ST95, and ST127. High concordance between phenotypic β-lactam resistance and genotypic findings was observed, as all β-lactam-resistant isolates carried at least one corresponding β-lactamase gene. Overall, these findings indicate that WGS can reliably confirm β-lactam resistance mechanisms and provide useful molecular epidemiological insights into E. coli isolates causing BSIs; however, conclusions are limited by the small sample size and single-center design, and larger multicenter studies are warranted to support routine surveillance applications.
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Afzal A, Gutierrez VP, Gomez E, Mon AM, Sarmiento CM, Khalid A, Polishchuk S, Al-Khateeb M, Yankulova B, Yusuf M, de Castro YS. 2022. Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx. Intl J Infect Dis 116: 43-46. https://doi.org/10.1016/j.ijid.2021.12.349.
Avershina E, Khezri A, Ahmad R. 2023. Clinical diagnostics of bacterial infections and their resistance to antibiotics—current state and whole-genome sequencing implementation perspectives. Antibiotics 12 (4): 781. https://doi.org/10.3390/antibiotics12040781.
Beshah D, Desta A, Belay G, Abebe T, Gebreselasie S, Tessema TS. 2022. Antimicrobial resistance and associated risk factors of Gram-negative bacterial bloodstream infections in Tikur Anbessa Specialized Hospital, Addis Ababa. Infect Drug Resist 15: 5043-5059. https://doi.org/10.2147/IDR.S371654.
Vanstokstraeten R, Pierard D, Crombé F, De Geyter D, Wybo I, Muyldermans A, Seyler L, Caljon B, Janssen T, Demuyser T. 2023. Genotypic resistance determined by whole-genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates. Sci Rep 13: 449. https://doi.org/10.1038/s41598-023-27723-z.
Chmielarczyk A, Pomorska-Wesołowska M, Romaniszyn D, Wójkowska-Mach J. 2021. Healthcare-associated laboratory-confirmed bloodstream infections—species diversity and resistance mechanisms. Intl J Environ Res Public Health 18: 2785. https://doi.org/10.3390/ijerph18052785.
Di Franco S, Alfieri A, Pace MC, Sansone P, Pota V, Fittipaldi C, Fiore M, Passavanti MB. 2021. Bloodstream infections from MDR bacteria. Life 11: 575. https://doi.org/10.3390/life11060575.
Endraswari P, Mertaniasih NM, Setiawan F, Paramita AL. 2022. Epidemiology of Escherichia coli as a critical pathogen of bloodstream infection patients in a tertiary referral hospital. Indones J Trop Infect Dis 10: 205-213. https://doi.org/10.20473/ijtid.v10i3.39494.
Forde BM, Bergh H, Cuddihy T, Hajkowicz K, Hurst T, Playford EG, Henderson BC, Runnegar N, Clark J, Jennison AV, Moss S. 2023. Clinical implementation of routine whole-genome sequencing for hospital infection control of multidrug-resistant pathogens. Clin Infect Dis 76: e1277-e1284. https://doi.org/10.1093/cid/ciac726.
Gambushe SM, Zishiri OT, El Zowalaty ME. 2022. Review of Escherichia coli O157:H7 prevalence, pathogenicity, heavy metal and antimicrobial resistance. Infect Drug Resist 15: 4645-4673. https://doi.org/10.2147/IDR.S365269.
Geurtsen J, de Been M, Weerdenburg E, Zomer A, McNally A, Poolman J. 2022. Genomics and pathotypes of the many faces of Escherichia coli. FEMS Microbiol Rev 46: fuac031. https://doi.org/10.1093/femsre/fuac031.
Grøv K, Håland E, Waagsbø B, Salvesen Ø, Damås JK, Afset JE. 2022. Empirical antimicrobial therapy for bloodstream infections not compliant with guidelines predicts poorer outcomes. Infect Dis (Lond) 54: 833-845. https://doi.org/10.1080/23744235.2022.2109208.
Hapsari A, Wijayana KA. 2024. Antibiotic therapy in neonatal sepsis. Med Health J 3: 249-256. https://doi.org/10.20884/1.mhj.2024.3.2.11437.
Korotetskiy IS, Shilov SV, Kuznetsova T, Kerimzhanova B, Korotetskaya N, Ivanova L, Zubenko N, Parenova R, Reva ON. 2023. Analysis of whole-genome sequences of pathogenic Gram-positive and Gram-negative isolates. Microorganisms 11: 323. https://doi.org/10.3390/microorganisms11020323.
Kwiecinski JM, Horswill AR. 2020. Staphylococcus aureus bloodstream infections: Pathogenesis and regulatory mechanisms. Curr Opin Microbiol 53: 51-60. https://doi.org/10.1016/j.mib.2020.02.005.
Li D, Elankumaran P, Kudinha T, Kidsley AK, Trott DJ, Jarocki VM, Djordjevic SP. 2023. Dominance of Escherichia coli sequence types ST73, ST95, ST127 and ST131. Microb Genom 9 (7): 001068. https://doi.org/10.1099/mgen.0.001068.
Lutwick L, Shweta F, Radel K, Bearman G. 2021. Central line-associated bloodstream infections. International Society for Infectious Diseases (ISID). Retrieved from: https://arpsp. cdc. gov/p rofile/infections/clabsi7hidden. [July, 8, 2025]
MacKinnon MC, McEwen SA, Pearl DL, Lyytikäinen O, Jacobsson G, Collignon P, Gregson DB, Valiquette L, Laupland KB. 2021. Mortality in Escherichia coli bloodstream infections. BMC Infect Dis 21: 606. https://doi.org/10.1186/s12879-021-06326-x.
Mostafa HH, Cameron A, Taffner SM, Wang J, Malek A, Dumyati G, Hardy DJ, Pecora ND. 2020. Genomic surveillance of ceftriaxone-resistant Escherichia coli. Front Microbiol 11: 1747. https://doi.org/10.3389/fmicb.2020.01747.
Neidhöfer C, Neuenhoff M, Jozič R, Atangcho B, Unsleber S, Neder U, Grumaz S, Parčina M. 2023. Exploring clonality and virulence gene associations in bloodstream infections. Front Cell Infect Microbiol 13: 1274573. https://doi.org/10.3389/fcimb.2023.1274573.
Nelwan EJ, Puspandari N. Paramita RI, Erlina, Renesteen E, Fadilah F. 2020. Whole genome sequencing data of Escherichia coli isolated from bloodstream infection patients in Cipto Mangunkusumo National Hospital, Jakarta, Indonesia. Data in Brief 30: 105631. https://doi.org/10.1016/j.dib.2020.105631.
Pokharel P, Dhakal S, Dozois CM. 2023. Diversity of Escherichia coli pathotypes. Microorganisms 11: 344. https://doi.org/10.3390/microorganisms11020344.
Schöneweck F, Schmitz RP, Rißner F, Scherag A, Löffler B, Pletz MW, Weis S, Brunkhorst FM, Hagel S. 2021. Epidemiology of bloodstream infections in Germany. Antimicrob Resist Infect Control 10: 132. https://doi.org/10.1186/s13756-021-00997-6.
Shahbazi R, Salmanzadeh-Ahrabi S, Aslani MM, Alebouyeh M, Falahi J, Nikbin VS. 2023. Genotypic and phenotypic characteristics of E. coli O25-B2-ST131. BMC Pediatr 23: 386. https://doi.org/10.1186/s12887-023-03866-w.
Sora VM, Meroni G, Martino PA, Soggiu A, Bonizzi L, Zecconi A. 2021. Extraintestinal pathogenic Escherichia coli. Pathogens 10: 1355. https://doi.org/10.3390/pathogens10111355.
Tyson GH, McDermott PF, Li C, Chen Y, Tadesse DA, Mukherjee S, Bodeis-Jones S, Kabera C, Gaines SA, Loneragan GH, Edrington TS. 2015. Whole-genome sequencing accurately predicts antimicrobial resistance in Escherichia coli. J Antimicrob Chemother 70: 2763-2769. https://doi.org/10.1093/jac/dkv186.
Weerdenburg E, Davies T, Morrow B, Zomer AL, Hermans P, Go O, Spiessens B, Van Den Hoven T, Van Geet G, Aitabi M, DebRoy C. 2023. Global distribution of O-serotypes and antibiotic resistance in ExPEC. Clin Infect Dis 76: e1236-e1243. https://doi.org/10.1093/cid/ciac421.